New York Times
health
F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer (Gift Article)
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Gift Links
Shared By
